Loading...

QGN

QGN

QIAGEN NV

(QGEN)

2024 6-K

Show Summary

Summary

Convertible Bonds Offering

29 Aug '25

Quarterly Report

21 Aug '25

Financial Results Adjusted

6 Aug '25

Management Update

27 Jun '25

Quarterly Report

12 May '25

Financial Results Release

8 May '25

Q1 2025 Results

8 Apr '25

Financial Results Report

6 Feb '25

Share Repurchase Plan

16 Jan '25

Shareholder Return Plan

13 Jan '25

Quarterly Report

7 Nov '24

Quarterly Results

7 Nov '24

Accountant Change

7 Nov '24

Convertible Bonds Offering

4 Sep '24

Convertible Bond Offering

3 Sep '24

Quarterly Report Filed

1 Aug '24

Financial Results Update

1 Aug '24

Annual Meeting Notice

1 Aug '24

Capital Markets Day

21 Jun '24

Product Discontinuation

6 Jun '24

Quarterly Report

30 Apr '24

Quarterly Results Report

30 Apr '24

Financial Results Announcement

8 Feb '24

Share Repurchase Plan

22 Jan '24

Shareholder Return Plan

8 Jan '24

External Links:

SEC

On June 6, 2024, QIAGEN N.V. announced the discontinuation of its NeuMoDx 96 and 288 Molecular Systems. This event is considered significant from an investor perspective.

AI Assistant

QIAGEN NV

2024

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.